NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
24.12
-0.07 (-0.29%)
At close: Sep 15, 2025, 4:00 PM EDT
24.12
0.00 (0.00%)
After-hours: Sep 15, 2025, 4:39 PM EDT
NAMS Stock Forecast
Stock Price Forecast
The 10 analysts that cover NAMS stock have a consensus rating of "Strong Buy" and an average price target of $41.4, which forecasts a 71.64% increase in the stock price over the next year. The lowest target is $27 and the highest is $52.
Price Target: $41.4 (+71.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $45 | Buy | Initiates | $45 | +86.57% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +61.69% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | +11.94% | Jul 17, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +74.13% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +65.84% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
30.38M
from 45.56M
Decreased by -33.32%
Revenue Next Year
30.89M
from 30.38M
Increased by 1.67%
EPS This Year
-1.43
from -2.56
EPS Next Year
-2.00
from -1.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 49.5M | 209.4M | |||
| Avg | 30.4M | 30.9M | |||
| Low | 21.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.5% | 589.3% | |||
| Avg | -33.3% | 1.7% | |||
| Low | -52.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.16 | -0.98 | |||
| Avg | -1.43 | -2.00 | |||
| Low | -1.66 | -2.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.